Granisetronum [INN-Latin] en es it fr

Granisetronum [INN-Latin] Brand names, Granisetronum [INN-Latin] Analogs

Granisetronum [INN-Latin] Brand Names Mixture

  • Tarka (Trandolapril + Verapamil hydrochloride)

Granisetronum [INN-Latin] Chemical_Formula


Granisetronum [INN-Latin] RX_link

Granisetronum [INN-Latin] fda sheet

Granisetronum_[INN-Latin] FDA

Granisetronum [INN-Latin] msds (material safety sheet)

Granisetronum_[INN-Latin] MSDS

Granisetronum [INN-Latin] Synthesis Reference

No information avaliable

Granisetronum [INN-Latin] Molecular Weight

312.41 g/mol

Granisetronum [INN-Latin] Melting Point

219 oC (HCl salt)

Granisetronum [INN-Latin] H2O Solubility

No information avaliable

Granisetronum [INN-Latin] State


Granisetronum [INN-Latin] LogP


Granisetronum [INN-Latin] Dosage Forms

Liquid; Tablet

Granisetronum [INN-Latin] Indication

For the prevention of: nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin.

Granisetronum [INN-Latin] Pharmacology

No information avaliable

Granisetronum [INN-Latin] Absorption

Absorption of is rapid and complete, though oral bioavailability is reduced to about 60% as a result of first pass metabolism.

Granisetronum [INN-Latin] side effects and Toxicity

LD50>2000 mg/kg (rat, oral)

Granisetronum [INN-Latin] Patient Information

Granisetronum [INN-Latin] Organisms Affected

Humans and other mammals